New Service: Alicanto for Antibody Discovery from Human Serum
We recently had the pleasure of attending the PEGS Boston Conference. We had the privilege of showcasing our work through a poster presentation, a talk, and an exhibit booth. Among the highlights were engaging with experts, exchanging ideas, and strengthening our network within the community. But perhaps the most important was launching our newest service: Alicanto For Antibody Discovery From Human Serum. It was truly a great time for Abterra Biosciences!
Watch our CEO, Dr. Natalie Castellana’s presentation on Discovering SARS-CoV2 Antibodies From Patient Serum With Alicanto below. This was our first antibody discovery project utilizing human serum!
Click below to watch the presentation.
Related Posts
Why Sequence My Antibody Protein?
Why should I sequence my antibody protein? Abterra Bio gives the top reasons to sequence your antibody protein.
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin
Infixion Bioscience and Abterra Bio set out to develop high affinity neurofibromin antibody reagents to detect NF1.
Customer Spotlight: Dr. Matthew Burchill
Dr. Burchill explains how Valens rescued his antibody and enabled him to continue his research. De novo antibody sequencing case study.
Get In Touch